Hemolytic Anemia
Symptoms, Doctors, Treatments, Advances & More

Learn About Hemolytic Anemia

View Main Condition: Anemia

What is the definition of Hemolytic Anemia?

Anemia is a condition in which the body does not have enough healthy red blood cells. Red blood cells provide oxygen to body tissues.

Normally, red blood cells last for about 120 days in the body. In people with hemolytic anemia, red blood cells in the blood are destroyed earlier than normal.

What are the alternative names for Hemolytic Anemia?

Anemia - hemolytic

What are the causes of Hemolytic Anemia?

The bone marrow is mostly responsible for making new red cells. Bone marrow is the soft tissue in the center of bones that helps form all blood cells.

Hemolytic anemia occurs when the bone marrow isn't making enough red cells to replace the ones that are being destroyed.

There are several possible causes of hemolytic anemia. Red blood cells may be destroyed due to:

  • An autoimmune problem in which the immune system mistakenly sees your own red blood cells as foreign substances and destroys them
  • Defects in the hemoglobin molecules inside red blood cells
  • Defects of the proteins that make up the internal framework of red blood cells
  • Exposure to certain chemicals, medicines, and toxins
  • Infections
  • Blood clots in small blood vessels
  • Transfusion of blood from a donor with a blood type that does not match yours
  • Faulty, damaged, or artificial heart valves
What are the symptoms of Hemolytic Anemia?

You may not have symptoms if the anemia is mild. If the problem develops slowly, the first symptoms may be:

  • Feeling weak or tired more often than usual, or with exercise
  • Feelings that your heart is pounding or racing
  • Headaches
  • Problems concentrating or thinking

If the anemia gets worse, symptoms may include:

  • Lightheadedness when you stand up
  • Pale skin
  • Shortness of breath
  • Sore tongue
  • Left upper abdominal pain due to an enlarged spleen
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hemolytic Anemia?

The treatment depends on the type and cause of the hemolytic anemia:

  • In emergencies, a blood transfusion may be needed.
  • For immune causes, medicines that suppress the immune system may be used.
  • When blood cells are being destroyed at a fast pace, the body may need extra folic acid and iron supplements to replace what is being lost.

In rare cases, surgery is needed to take out the spleen. This is because the spleen acts as a filter that removes abnormal cells from the blood.

Who are the top Hemolytic Anemia Local Doctors?
Elite in Hemolytic Anemia
Hematology | Pediatrics
Elite in Hemolytic Anemia
Hematology | Pediatrics
Referral may be required

Duke Adult Comprehensive Sickle Cell Center - Clinic 2N

40 Duke Medicine Cir, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Nirmish Shah is a Hematologist and a Pediatrics provider practicing medicine in Durham, North Carolina. Dr. Shah is rated as an Elite provider by MediFind in the treatment of Hemolytic Anemia. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Shah is currently accepting new patients.

Elite in Hemolytic Anemia
Hematology | Pediatrics
Elite in Hemolytic Anemia
Hematology | Pediatrics
Referral may be required

Duke Adult Comprehensive Sickle Cell Center - Clinic 2N

40 Duke Medicine Cir, 
Durham, NC 
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

John Strouse is a Hematologist and a Pediatrics provider practicing medicine in Durham, North Carolina. Dr. Strouse is rated as an Elite provider by MediFind in the treatment of Hemolytic Anemia. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Thrombectomy, and Bone Marrow Aspiration. Dr. Strouse is board certified in American Board Of Internal Med, Hematology , American Board Of Pediatrics, Pediatric Hematology-Oncology, and American Board Of Pediatrics, General Pediatrics . Dr. Strouse is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Hemolytic Anemia
Elite in Hemolytic Anemia
Referral may be required

Jefferson Hematology - Honickman Center

1101 Chestnut Street, Floor 8, 
Philadelphia, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Sophie Lanzkron is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Lanzkron is rated as an Elite provider by MediFind in the treatment of Hemolytic Anemia. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Lanzkron is board certified in Hematology. Dr. Lanzkron is currently accepting new patients.

What is the outlook (prognosis) for Hemolytic Anemia?

The outcome depends on the type and cause of hemolytic anemia. Severe anemia can make heart disease, lung disease, or cerebrovascular disease worse.

When should I contact a medical professional for Hemolytic Anemia?

Contact your health care provider if you develop symptoms of hemolytic anemia.

What are the latest Hemolytic Anemia Clinical Trials?
Sickle Cell Disease Stem Cell Mobilization and Apheresis Using Motixafortide

Summary: This study is being done to see if the study drug, motixafortide, is safe in participants with sickle cell disease (SCD). Investigators also want to see if the drug will help the body increase the number of stem cells that can be collected for possible future transplant use. PRIMARY OBJECTIVE * To characterize the safety and tolerability of motixafortide in participants with SCD as determined by t...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Background: Severe aplastic anemia (SAA), and myelodysplastic syndrome (MDS), and paroxysmal nocturnal hemoglobinuria (PNH) cause serious blood problems. Stem cell transplants using bone marrow or blood plus chemotherapy can help. Researchers want to see if using peripheral blood stem cells (PBSCs) rather than bone marrow cells works too. PBSCs are easier to collect and have more cells that help transplants.

Who are the sources who wrote this article ?

Published Date: January 29, 2026
Published By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Elghetany MT, Banki K. Erythrocytic disorders. In: McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Philadelphia, PA: Elsevier; 2022:chap 33.

Gallagher PG. Hemolytic anemias: red blood cell membrane and metabolic defects. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 147.

Mentzer WC, Schrier SL. Extrinsic nonimmune hemolytic anemia. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 48.

Michel M, Jäger U. Autoimmune hemolytic anemia. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 47.

Michel M. Autoimmune and intravascular hemolytic anemias. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 146.